The Gujarat Themis Biosyn Limited (GTBL) Story
Gujarat Themis Biosyn Limited (GTBL) was incorporated in 1981 as a joint-sector company with Gujarat Industrial Investment Corporation (GIIC) Limited.
GTBL commenced operations with the production of Erythromycin and its salts. In 1991, ownership of the Company was transferred from Chemosyn Pvt. Ltd. to Pharmaceutical Business Group (India) Ltd. (PBG).
Subsequently, Themis Medicare and PBG entered into a technical and financial collaboration with Yuhan Corporation, South Korea. With the support of Yuhan Corporation’s technical expertise and know-how, GTBL became the first company in India to commence the commercial production and marketing of Rifampicin, an important anti-tuberculosis medicine.
This milestone marked a significant achievement in GTBL’s history and contributed to the development of India’s pharmaceutical manufacturing capabilities, particularly in the field of anti-tuberculosis medicines.